1. Home
  2. EBS vs VERI Comparison

EBS vs VERI Comparison

Compare EBS & VERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBS
  • VERI
  • Stock Information
  • Founded
  • EBS 1998
  • VERI 2014
  • Country
  • EBS United States
  • VERI United States
  • Employees
  • EBS N/A
  • VERI N/A
  • Industry
  • EBS Biotechnology: Pharmaceutical Preparations
  • VERI EDP Services
  • Sector
  • EBS Health Care
  • VERI Technology
  • Exchange
  • EBS Nasdaq
  • VERI Nasdaq
  • Market Cap
  • EBS 529.9M
  • VERI 438.8M
  • IPO Year
  • EBS 2006
  • VERI 2017
  • Fundamental
  • Price
  • EBS $10.93
  • VERI $4.18
  • Analyst Decision
  • EBS Strong Buy
  • VERI Strong Buy
  • Analyst Count
  • EBS 1
  • VERI 5
  • Target Price
  • EBS $15.00
  • VERI $10.00
  • AVG Volume (30 Days)
  • EBS 1.5M
  • VERI 5.5M
  • Earning Date
  • EBS 10-29-2025
  • VERI 11-06-2025
  • Dividend Yield
  • EBS N/A
  • VERI N/A
  • EPS Growth
  • EBS N/A
  • VERI N/A
  • EPS
  • EBS 1.35
  • VERI N/A
  • Revenue
  • EBS $788,900,000.00
  • VERI $98,027,000.00
  • Revenue This Year
  • EBS N/A
  • VERI $19.12
  • Revenue Next Year
  • EBS $15.42
  • VERI $18.83
  • P/E Ratio
  • EBS $8.11
  • VERI N/A
  • Revenue Growth
  • EBS N/A
  • VERI 0.74
  • 52 Week Low
  • EBS $4.02
  • VERI $1.22
  • 52 Week High
  • EBS $13.41
  • VERI $9.42
  • Technical
  • Relative Strength Index (RSI)
  • EBS 57.23
  • VERI 39.98
  • Support Level
  • EBS $9.02
  • VERI $3.59
  • Resistance Level
  • EBS $10.29
  • VERI $4.50
  • Average True Range (ATR)
  • EBS 0.58
  • VERI 0.49
  • MACD
  • EBS -0.03
  • VERI -0.15
  • Stochastic Oscillator
  • EBS 93.69
  • VERI 19.05

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

About VERI Veritone Inc.

Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel, and India.

Share on Social Networks: